UK Public Sector Contracts & Tenders

Cellular Pathology laboratories in the North East North Cumbria (NENC) region currently maintain long term (30+ years) archives of all wax tissue blocks and microscope slides that are produced. The North East & North Cumbria Pathology network (NENC) has obtained limited Digital Diagnostics Capability funding from NHS England for purchase of an “advanced archiving solution” that will both save time for laboratory staff and dramatically reduce the risk of misfiling and loss of tissue blocks and slides. Any proposed archiving solution must be compatible with the current and legacy linear and/or data matrix barcodes on blocks and slides for identification of the materials

Pre Market Engagement for a Commercial Laundry Service Solution.

Emergency Contact Solution

Contact Centre Solution PIN

It is intended to host a Market Engagement Event for providers of VHP Isolator Technologies on the 25th May 2023 to be held on site at: North East and North Cumbria Manufacturing Facility, Northumbria Healthcare NHS manufacturing and innovation hub, Seaton Delaval, Northumberland. Companies interested in attending the event must contact Kevin Marshall e-mail kevin.marshall@northumbria-healthcare.nhs.uk to obtain an information pack.

Design, Supply and Installation of Sterilisation Equipment

Northumbria Healthcare Facilities Management Limited (NHFML) a wholly owned subsidiary of Northumbria Healthcare Foundation Trust (NHFT) is exploring the possibility of procuring a framework for the provision of Construction Works and Associated Professional Services. Further information can be found in the Preliminary Market Engagement Document.

Pre-Market Engagement exercise to explore options for a Batch Records and Labelling System. This engagement aims to identify potential output capabilities and process streamlining benefits available to the Medicines Manufacturing Centre.

Pre-Market Engagement exercise to explore options for a Batch Records and Labelling System. This engagement aims to identify potential output capabilities and process streamlining benefits available to the Medicines Manufacturing Centre.